Geneva Biotech is a privately held biotechnology company, based in Geneva, Switzerland. Founded in 2012

Geneva Biotech MultiBacMam™ CRISPR

Intelligent DNA delivery systems

Welcome Guest \\ Login

MultiBacMam™ CRISPR

Technology Description

We are designing baculoviral vectors adapted for CRISPR-based genome engineering. With unprecedented DNA cargo capacity and integration efficiency, they will be the most powerful CRISPR delivery system on the market

Technology Release Q3 2019

User Manual and Other Downloads

Click here for DNA vector sequences

Click here to download Cre-ACEMBLER User Manual 3.0

Click here to download Cre-ACEMBLER Short Description

Click here to download Cre-ACEMBLER for Windows

Click here to download Cre-ACEMBLER for Linux

Kits

MultiBacMam™ CRISPR Kit 1,490.00€ ENQUIRY

Competent Cells

DH10 CRISPR 960.00€ ENQUIRY
ig™ 10B (12 X 100µl) 760.00€ ENQUIRY
PirHC (12 x 100µl) 960.00€ ENQUIRY

Plasmids

pACEMam CRISPR (5µg) 419.00€ ENQUIRY

Dual Plasmids

pUCDM MultiBacMam Cargo (5µg) 419.00€ ENQUIRY
pUCDM MultiBacMam Cargo_GFP (5µg) 419.00€ ENQUIRY

Enquiry

E.coli cell expression
MultiColi™

Research Highlights

our r&d View all

Latest News

T-CELL AND B-CELL TRANSDUCTION TECHNOLOGIES Geneva Biotech releases the first efficient non-lentiviral transduction system for immortal T-cells and B-cells. Please ...

View all

Contact Us